SCHEMBL1785760

SCHEMBL1785760

[CH2]CN1C[C@@H]2C[C@H]1CO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24801869 0.78
SCHEMBL24337595 0.77 TP53 (0.35)
SCHEMBL12717919 0.75 ESR1 (0.34)
SCHEMBL5069790 0.75 GAA (0.36)
SCHEMBL23775665 0.75 KIF11 (0.32)
SCHEMBL21772277 0.75 GAA (0.36)
SCHEMBL15366079 0.75 ESR1 (0.32)
SCHEMBL23374669 0.74 PIK3CD (0.37)
Hydrochloric Acid SCHEMBL25368246 0.74 GAA (0.35)
Hydrochloric Acid SCHEMBL25367847 0.74 ESR1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130203730-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2013-08-08 US disclosed
EP-2607357-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS Astrazeneca AB (SE) 2013-06-26 EP disclosed
US-20120115845-A1 THERAPEUTIC AGENTS ALLEN JACK MCQUEEN (GB) 2012-05-10 US disclosed
US-20110124621-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2011-05-26 US disclosed
US-20090186870-A1 Therapeutic Agents - 802 ASTRAZENECA AB (SE) 2009-07-23 US disclosed